THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2018

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2018

WEBINARS

Register Now and
On Demand

Home » MARKETPLACE, Marketplace Archives

Unyvero System gets de novo clearance

 

June 2018—Curetis has been granted de novo clearance by the FDA to market the Unyvero System and Lower Respiratory Tract Infection Application Cartridge in the U.S. The sample-to-answer Unyvero System with the Unyvero LRT Application Cartridge provide rapid infectious disease testing directly from aspirate samples in less than five hours. With 29 multiplexed PCR assays, the system can detect more than 30 Gram-positive and Gram-negative bacterial organisms known to cause lower respiratory tract infections, as well as 10 genetic markers for antibiotic resistance, including carbapenem and third-generation cephalosporins.

Curetis USA, 619-452-3644

Print Friendly, PDF & Email
Tags:

X